Clinical Trials Browser

Withdrawn × INDUSTRY × Prostatic Neoplasms × Clear all

NCT06765902 2026-05-05

Immunotherapy Before and After Surgery

Phase 2 Withdrawn

Prostatic Neoplasms

NCT06765954 2026-05-05

Immunotherapy With N 803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer.

Phase 2 Withdrawn

Prostatic Neoplasms

NCT06881823 2025-12-29

NeoPSMA

Phase 1/2 Withdrawn

Prostatic Neoplasms

NCT04580667 2025-08-28

Determination of Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict GI Radiation Toxicity

Prostatic Neoplasms

NCT06795178 2025-04-27

KATANA E3M

Phase 3 Withdrawn

Prostatic Neoplasms

NCT06795191 2025-04-27

KATANA E6M

Phase 3 Withdrawn

Prostatic Neoplasms

NCT06457854 2025-03-12

PROCeed-BR

Prostatic Neoplasms

NCT02608359 2025-02-03

A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer

Prostatic Neoplasms

NCT02905201 2025-02-03

TOGETHER

Prostatic Neoplasms

NCT04985357 2024-11-25

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

BreastEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Anus Neoplasms, Appendiceal Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Laryngeal Neoplasms, Lip Neoplasms, Lung Neoplasms, Mesothelioma, Mouth Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Paranasal Sinus Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Thymoma, Vulvar Neoplasms, Pleural Effusion, Malignant, Carcinoma, Neuroendocrine, Cholangiocarcinoma, Carcinoma, Ductal, Small Cell Lung Carcinoma

NCT03990194 2024-10-31

LEPTO

Prostatic Neoplasms

NCT03494803 2023-12-22

Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC

Prostatic Neoplasms

NCT05454371 2023-11-13

URODETECT-WP2

Phase NA Withdrawn

Neoplasms, Prostatic Neoplasms

NCT01792882 2023-02-28

GBCPRT0008

BreastGastrointestinalGenitourinaryOther hematologic neoplasmThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

NCT05191017 2022-08-05

Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC

Phase 1/2 Withdrawn

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT03495479 2021-10-18

CAMPAS

Prostatic Neoplasms

NCT01566045 2021-04-28

MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate Cancer

Phase NA Withdrawn

Prostatic Neoplasms

NCT00621413 2021-04-19

Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer

Neoplasms, Prostatic Neoplasms

NCT03589781 2021-03-30

Investigating the Effects of Mikei® Red Reishi Essence EX on the Immune System of Prostate Cancer Patients and Patients With Non-cancerous Conditions of the Prostate

Phase NA Withdrawn

Prostatic Neoplasms

NCT00537849 2019-04-10

Investigational Study For the Treatment of Localized (T1c/T2a) Prostate Cancer With High Intensity Focused Ultrasound (HIFU) Using the Sonablate 500 (SB-500) System in Canada

Phase NA Withdrawn

Prostatic Neoplasms

NCT02742259 2019-03-26

VPCA-B+PIV

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT03325127 2018-10-31

Outcomes of mCRPC Patients Treated With Ra-223 Concomitant With Abiraterone or Enzalutamide- A Chart Review Study

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT01188408 2018-03-12

Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms

NCT00691899 2016-08-12

A Study to Assess the Effects of MK0822 in Prolonging Time to First Bone Metastasis in Men With Castration-Resistant Prostate Cancer (0822-030)

Phase 3 Withdrawn

Prostatic Neoplasms

NCT01173146 2016-05-25

Imaging of Residual Tumor During Prostatectomy

Prostatic Neoplasms

NCT01692483 2015-12-02

Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer

Prostatic Neoplasms

NCT01279785 2015-11-25

A Pilot Study of 123I-MIP-1072 SPECT/CT Imaging With Optional Compact Gamma Camera Probe Imaging in Men With Prostate Cancer Undergoing Prostatectomy

Adenocarcinoma, Prostatic Neoplasms

NCT02424513 2015-06-02

A Study of Positron Emission Tomography (PET) With [89]Zr-Df-IAb2M in Patients With High-risk Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms

NCT01734681 2014-02-19

Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms

NCT01214291 2013-11-15

TREAT2

Phase 3 Withdrawn

Prostatic Neoplasms, Fractures, Bone

NCT01197209 2013-08-23

Neoadjuvant Study of In-situ REIC/Dkk-3 in Prostate Cancer

Phase 1 Withdrawn

Neoplasms, Prostatic Neoplasms

NCT00043212 2013-05-01

Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective.

Phase 3 Withdrawn

Neoplasms, Prostatic Neoplasms

NCT00728533 2011-03-18

Open-Label, Randomised Parallel-Group Study

Phase 3 Withdrawn

Prostatic Neoplasms

NCT00255268 2007-08-28

CMAB vs IMAB in Metastatic Prostate Cancer

Phase 4 Withdrawn

Prostatic Neoplasms